MedCity are working with King’s College London, Imperial College London and University College London, in establishing a new Network for those working in advanced therapies. The Advanced Therapies Network aims to support knowledge exchange within the academic base and industry in the field of advanced therapies.

Building on the previous work of the London Regenerative Medicine Network, we will organise four events a year to support connections and collaborations between companies and academia working in advanced therapies, while providing the opportunity to discuss and debate topics which will be of interest to its members.

The launch of the Network is taking place on 8th November 2018 at the Royal College of Physicians in Central London, supported by the NIHR Office for Clinical Research Infrastructure (NOCRI).

Agenda

9:00 – 9:30 – Registration

9:30 – 9:45 – Welcome and Introduction to Connecting Capabilities Fund and the Advanced Therapies Network – Sarah Haywood, MedCity

9:45 – 10:00 – New cell and gene based therapies for cancer – Prof Farzin Farzaneh, King’s College London

10:00 – 10:15 – Gene Therapy for Cystic Fibrosis, moving from academia to industry adoption – Prof Eric Alton, Imperial College London

10:15 – 10:30 – AAV-based gene therapy entering the stage for childhood diseases – Prof Thomas Voit, University College London

10:30 – 10:45 – Insights into building a global gene therapy company via multiple academic alliances – Adrien Lemoine, Orchard Therapeutics

10:45 – 10:55 – Panel Q&As

10:55 – 11:00 – Invite to become a Member – Sarah Haywood, MedCity

11:00 -12:00 – Networking

Please sign up here: https://advanced-therapies-network.eventbrite.co.uk